| Literature DB >> 6351886 |
F M Ubeira, R Seoane, E Puentes, J Faro, B J Regueiro.
Abstract
Clofibrate (CPIB) is a drug applied as an antilipidaemic agent in mammals. In this work we have tested its efficacy in vivo on the growth kinetics of P 1798(sc) lymphoma transplanted to recipient (BALB/c x AKR)F1 mice. Our results show a facilitation of the tumour growth rate in treated recipients. This fact may be related to an effect of the agent on the recipient which produces a decrease in the immune response as was confirmed on testing CPIB on thymus-dependent antigens in haemolytic plaque assays.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6351886 PMCID: PMC2011464 DOI: 10.1038/bjc.1983.207
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640